Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Clear Biotech is a private Chinese diagnostics and medical-device distribution company focused on point-of-care testing products and molecular diagnostic systems. The company appears to operate primarily as a commercial distributor rather than a drug developer, with a geographic emphasis on northern China. Publicly available sources describe Beijing Clear as a distributor to hospitals, physician office laboratories, and other primary care settings, and as a strategic Greater China partner for Curetis/OpGen's Unyvero molecular diagnostics platform. Its disclosed activities include local marketing, sales, logistics, and regulatory support for imported diagnostic products in China. Based on the available evidence, it is best characterized as a healthcare commercial/distribution company rather than a therapeutics biotech with an internal drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Clear Biotech.